Ocumension Therapeutics Competitors and Similar CompaniesClear all

Ocumension Therapeutics's competitors and similar companies include DaVita, UT Health, Strive Health and Green Cross Lab Cell.

	Ocumension Therapeutics Ocumension Therapeutics (欧康维视生物医药（上海）有限公司) is a provider of ophthalmic pharmaceutical services.	DaVita DaVita is a kidney care company focused on dialysis and related lab solutions.	UT Health UT Health is a provider of cancer treatments.	Strive Health Strive Health is a provider of kidney care solutions.	Green Cross Lab Cell Green Cross Lab Cell (경기도 용인시 기흥구) is a biotechnology company that develops clinical laboratory services and products.
Founding Date	Founding Date 2017	Founding Date 1994	Founding Date 1974	Founding Date 2018	Founding Date 2011
Type	Type Public	Type Public	Type Private	Type Private	Type Public
Tags	Tags Healthcare medical diagnostics therapy	Tags Healthcare medical diagnostics therapy	Tags Healthcare medical diagnostics therapy	Tags Healthcare medical diagnostics therapy	Tags Healthcare medical diagnostics therapy
Locations	Locations HQ	Locations Denver, US HQ Bogotá, CO Hamburg, DE Hong Kong, HK Kuala Lumpur, MY Amsterdam, NL Wrocław, PL see more	Locations HQ	Locations Denver, US HQ	Locations Yongin-si, KR HQ
Employees	Employees N/A	Employees 76,0009% increase	Employees 8,2711% increase	Employees 514	Employees 761
Financial
Revenue (est.)	Revenue (est.) ¥804.4m (FY, 2025)	Revenue (est.) $13.6b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₩174.5b (FY, 2024)
Cost of goods	Cost of goods ¥299.7m (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A	Cost of goods ₩128.5b (FY, 2024)
Gross profit	Gross profit ¥508.7m (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit N/A	Gross profit ₩46b (FY, 2024)
Net income	Net income (¥158.8m) (FY, 2025)	Net income $1.1b (FY, 2025)	Net income N/A	Net income N/A	Net income (₩75.7b) (FY, 2024)